Shenzhen Chipscreen Biosciences Co Market cap
What is the Market cap of Shenzhen Chipscreen Biosciences Co?
The Market cap of Shenzhen Chipscreen Biosciences Co., Ltd. is $1.38B
What is the definition of Market cap?
Market capitalization is the market value at a point in time of the shares outstanding of a publicly traded company, being equal to the share price at that point of time times the number of shares outstanding.
= outstanding shares * previous day’s close
As outstanding stock is bought and sold in public markets, capitalization could be used as an indicator of public opinion of a company's net worth and is a determining factor in some forms of stock valuation.
Market capitalization is used by the investment community in ranking the size of companies, as opposed to sales or total asset figures. It is also used in ranking the relative size of stock exchanges, being a measure of the sum of the market capitalizations of all companies listed on each stock exchange. In performing such rankings, the market capitalizations are calculated at some significant date, such as 30 June or 31 December.
The total capitalization of stock markets or economic regions may be compared with other economic indicators. The total market capitalization of all publicly traded companies in the world was US$51.2 trillion in January 2007 and rose as high as US$57.5 trillion in May 2008 before dropping below US$50 trillion in August 2008 and slightly above US$40 trillion in September 2008. In 2014 and 2015, global market capitalization was US$68 trillion and US$67 trillion, respectively.
Market cap of companies in the Health Care sector on SSE compared to Shenzhen Chipscreen Biosciences Co
What does Shenzhen Chipscreen Biosciences Co do?
Shenzhen Chipscreen Biosciences Co., Ltd. engages in the research, development, and sale of original small molecule drugs. The company develops precursor compounds and original new drug product lines that are in various research phase of the specific global intellectual property protection in three areas, such as cancer, metabolic diseases, and autoimmune diseases. Shenzhen Chipscreen Biosciences Co., Ltd. was founded in 2001 and is based in Shenzhen, China.
Companies with market cap similar to Shenzhen Chipscreen Biosciences Co
- Nuveen S&P 500 Buy-Write Income Fund has Market cap of $1.37B
- Mangalore Refinery and Petrochemicals has Market cap of $1.38B
- Encore Capital has Market cap of $1.38B
- Brookfield Business Partners LP has Market cap of $1.38B
- Upstart has Market cap of $1.38B
- Picanol NV has Market cap of $1.38B
- Shenzhen Chipscreen Biosciences Co has Market cap of $1.38B
- HudBay Minerals has Market cap of $1.38B
- Ready Capital Corp has Market cap of $1.38B
- HMS Networks AB (publ) has Market cap of $1.38B
- EchoStar Corp has Market cap of $1.38B
- Eagle Bancorp Inc (MD) has Market cap of $1.38B
- Ruffer Investment Co has Market cap of $1.38B